Crinetics Pharmaceuticals, Inc. Increase (Decrease) in Accounts Receivable
Crinetics Pharmaceuticals, Inc. (CRNX) reported Increase (Decrease) in Accounts Receivable of $11.37 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-03
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was $6.27M.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $5.09M.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-06-30 was $0.00.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-03-31 was $0.00.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts receivable for fiscal 2025 was $592.00K.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $0.00.
- Crinetics Pharmaceuticals, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $0.00.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|
| 2026-06-30 | $6.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $11.37M 10-Q · filed 2026-08-03 | |
| 2026-03-31 | $5.09M 10-Q · filed 2026-05-07 | ||
| 2025-12-31 | $592.00K 10-K · filed 2026-02-26 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-03 | $0.00 10-Q · filed 2026-08-03 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | ||
| 2024-12-31 | $0.00 10-K · filed 2026-02-26 | ||
| 2023-12-31 | $0.00 10-K · filed 2026-02-26 |